Metabolomics Reveals Metabolic Characteristics of Functional Cure in Chronic Hepatitis B Treated With Entecavir Combined With Pegylated Interferon Alpha.

Wang J, Kong X, Xu H, Zhang W, Peng P

Open source

DOI
10.1155/bmri/1031453
Published
2026
Container
BioMed research international
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/bmri/1031453,
  title = {Metabolomics Reveals Metabolic Characteristics of Functional Cure in Chronic Hepatitis B Treated With Entecavir Combined With Pegylated Interferon Alpha.},
  author = {Wang J and Kong X and Xu H and Zhang W and Peng P},
  year = {2026},
  journal = {BioMed research international},
  doi = {10.1155/bmri/1031453},
  url = {https://doi.org/10.1155/bmri/1031453}
}

RIS

TY  - JOUR
TI  - Metabolomics Reveals Metabolic Characteristics of Functional Cure in Chronic Hepatitis B Treated With Entecavir Combined With Pegylated Interferon Alpha.
AU  - Wang J
AU  - Kong X
AU  - Xu H
AU  - Zhang W
AU  - Peng P
PY  - 2026
JO  - BioMed research international
DO  - 10.1155/bmri/1031453
UR  - https://doi.org/10.1155/bmri/1031453
ER  - 

APA

J, W., X, K., H, X., W, Z., & P, P. (2026). Metabolomics Reveals Metabolic Characteristics of Functional Cure in Chronic Hepatitis B Treated With Entecavir Combined With Pegylated Interferon Alpha.. BioMed research international. https://doi.org/10.1155/bmri/1031453

Source records